Projects per year
Personal profile
Biography
Professor Ian Davis MBBS(Hons) PhD FRACP FAChPM FAHMS is a medical oncologist and is Professor of Medicine and Head of the Eastern Health Clinical School, Monash University and Eastern Health, in Melbourne, Australia. He is an NHMRC Leadership Fellow L3 (2023-2027). He is an Affiliate Professor of Deakin University, Associate Professor of the University of Melbourne, and an Associate of the University of Sydney. His primary clinical interests are in urologic cancers, and his primary research interests are in cancer immunology and the biology of urologic cancers. Prof Davis is a member of the Medical & Scientific Committee and of the Standing Subcommittee on Research for the Cancer Council Victoria. He founded the Urologic Oncology Group of the Clinical Oncology Society of Australia (COSA), is a member of COSA Council, and previously a COSA Board director. Prof Davis is founder of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Ltd (ANZUP). He is chair of the ANZUP Board and of its Scientific Advisory Committee. Prof Davis has published over 300 papers with over 17,000 citations, attracted over $30M in grant funding, and been involved in over 200 clinical trials for which he was global or site Principal Investigator in over 130.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Cancer immunology, PhD, University of Melbourne
Award Date: 1 May 1997
Medicine, MB BS (First class honours), MONASH UNIVERSITY
Award Date: 7 Dec 1983
External positions
Professor of Medicine, Eastern Health
1 Jul 2012 → …
Chair, Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
8 Oct 2008 → …
Research area keywords
- Oncology
- Cancer Immunology
- Immunotherapy
- Genitourinary cancers
- VIC
- Bladder cancer
- Renal cell carcinoma
- Germ cell cancer
- Melanoma
- Clinical research
- Clinical trials
- Cancer biology
Network
-
Integrative Molecular Characterization and Biomarker Validation in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Hamid, A., Sweeney, C. J., Corcoran, N., Davis, I., Van Allen, E. M., Attard, G., Azad, A. & Wang, X. V.
1/09/21 → 31/08/25
Project: Research
-
Actionable data for clinicians and external accreditors in support of quality care provision and continuous accreditation.
Wybrow, M., Taniar, D., Davis, I., Kokai, Z., Luxford, K. & Board, N.
Monash University – Internal Faculty Contribution
1/04/21 → 1/03/25
Project: Research
-
Bio-Rad CFX Opus 96 Real-Time PCR System
Davis, I., Sengupta, S. & Sluka, P.
1/10/21 → 31/12/22
Project: Research
-
Genomic & immunological predictors of response to intravesical therapy
Sengupta, S., Tran, B., Sluka, P., Anderson, P., Hayne, D. & Davis, I.
17/09/19 → 16/09/20
Project: Research
-
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Bakouny, Z., El Zarif, T., Dudani, S., Connor Wells, J., Gan, C. L., Donskov, F., Shapiro, J., Davis, I. D., Parnis, F., Ravi, P., Steinharter, J. A., Agarwal, N., Alva, A., Wood, L., Kapoor, A., Ruiz Morales, J. M., Kollmannsberger, C., Beuselinck, B., Xie, W., Heng, D. Y. C., & 1 others , Feb 2023, In: European Urology. 83, 2, p. 145-151 7 p.Research output: Contribution to journal › Article › Research › peer-review
10 Citations (Scopus) -
Attitudes, knowledge and practice behaviours of oncology health care professionals towards lesbian, gay, bisexual, transgender, queer and intersex (LGBTQI) patients and their carers: A mixed-methods study
Ussher, J. M., Perz, J., Allison, K., Power, R., Hawkey, A., Dowsett, G. W., Hickey, M., Parton, C., McDonald, F. E. J., Davis, I. D., Quinn, G. P., Boydell, K., Robinson, K. H., Chambers, S. & Anazodo, A., 2022, (Accepted/In press) In: Patient Education and Counseling. 12 p.Research output: Contribution to journal › Article › Research › peer-review
Open Access10 Citations (Scopus) -
Be Careful Not To ARAMIS the Point
Davis, I. D., 4 Oct 2022, (Accepted/In press) In: European Urology. 2 p.Research output: Contribution to journal › Editorial › Other › peer-review
-
Combination therapy in metastatic hormone-sensitive prostate cancer: is three a crowd?
Davis, I. D., Mar 2022, In: Therapeutic Advances in Medical Oncology. 14, p. 1-12 12 p.Research output: Contribution to journal › Review Article › Research › peer-review
Open Access4 Citations (Scopus) -
Combined impact of lipidomic and genetic aberrations on clinical outcomes in metastatic castration-resistant prostate cancer
Mak, B., Lin, H-M., Kwan, E. M., Fettke, H., Tran, B., Davis, I. D., Mahon, K., Stockler, M. R., Briscoe, K., Marx, G., Zhang, A., Crumbaker, M., Tan, W., Huynh, K., Meikle, T. G., Mellett, N. A., Hoy, A. J., Du, P., Yu, J., Jia, S., & 7 others , Dec 2022, In: BMC Medicine. 20, 1, 14 p., 112.Research output: Contribution to journal › Article › Research › peer-review
Open Access5 Citations (Scopus)